ABCL AbCellera Biologics

AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023

VANCOUVER, British Columbia--(BUSINESS WIRE)--

(Nasdaq: ABCL) today announced that it will present at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023, at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

A live audio webcast of the presentation may be accessed through a link that will be posted on . A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit .

Source: AbCellera Biologics Inc.

EN
23/02/2023

Underlying

ABCLAbCellera Biologics

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AbCellera Biologics

Jonathan Moreland
  • Jonathan Moreland
Free Trial
USNA USANA Health Sc...
UCTT Ultra Clean Hol... ... (+27)

InsiderInsights.com Daily Ratings Report: March 11, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

USNA USANA HEALTH SCIENCES INC.
UCTT ULTRA CLEAN HOLDINGS INC.
TTSH TILE SHOP HOLDINGS INC.
TRS TRIMAS CORPORATION
SRE SEMPRA ENERGY
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
MGPI MGP INGREDIENTS INC.
MPLX MPLX LP
PETS PETMED EXPRESS INC.
TREE LENDINGTREE INC.
STXS STEREOTAXIS
ELAN ELANCO ANIMAL HEALTH INC.
NFE NEW FORTRESS ENERGY
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
RC GRUPO RADIO CENTRO S.A.B. DE C.V.
ABCL ABCELLERA BIOLOGICS
ALIT ALIGHT
IE INC. / DELAWARE
ECAT IVANHOE ELECTRIC INC
MEGI BLACKROCK ESG CAP ALLOCATION TR
SMRT MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
CUBA SMARTRENT INC
PSBD THE HERZFELD CARIBBEAN BASIN FUND
BHRB INC.
VG PALMER SQUARE CAPITAL BDC INC
BURKE HERBERT FINANCIAL SERVICES CORP
VENTURE GLOBAL INC.
03/11/25 March 11, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
MGPI MGP Ingredients...
HSII Heidrick & Stru... ... (+41)

InsiderInsights.com Daily Ratings Report: March 10, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

MGPI MGP INGREDIENTS INC.
HSII HEIDRICK & STRUGGLES INTERNATIONAL INC.
EVH
CE EVOLENT HEALTH INC CLASS A
CDXS CELANESE CORPORATION
APPS CODEXIS
AAP DIGITAL TURBINE
MEDP ADVANCE AUTO PARTS INC.
FSLR MEDPACE HOLDINGS INC.
NSA FIRST SOLAR INC.
CLF NATIONAL STORAGE AFFILIATES TRUST
RCII CLIFFS NATURAL RESOURCES INC.
STXS RENT-A-CENTER INC
GRX STEREOTAXIS
AMPY THE GABELLI HEALTHCARE & WELLNESSRX TRUST
RC AMPLIFY ENERGY
ACA GRUPO RADIO CENTRO S.A.B. DE C.V.
ENX ARCOSA
BIGC EATON VANCE NEW YORK MUNICIPAL BOND FUND
CZR BIGCOMMERCE HOLDINGS
NOG INC.
PRDO CAESARS ENTERTAINMENT INC
ABCL NORTHERN OIL AND GAS
UAN PERDOCEO EDUCATION CORP
INDI ABCELLERA BIOLOGICS
IE CVR PARTNERS LP
ECAT INDIE SEMICONDUCTOR INC
MEGI IVANHOE ELECTRIC INC
RCEL BLACKROCK ESG CAP ALLOCATION TR
SBGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
TKO AVITA MEDICAL INC
CUBA SINCLAIR INC
BHRB TKO GROUP HOLDINGS
GAM INC.
SUNS THE HERZFELD CARIBBEAN BASIN FUND
GF INC.
BURKE HERBERT FINANCIAL SERVICES CORP
GENERAL DE ALQUILER DE MAQUINARIA
SUNRISE REALTY TRUST
THE NEW GERMANY FUND
INC.
03/10/25 March 10, 2025 1 EN
Jonathan Moreland
  • Jonathan Moreland
Free Trial
SRE SEMPRA ENERGY
PEB Pebblebrook Hot... ... (+24)

InsiderInsights.com Daily Ratings Report: March 7, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

SRE SEMPRA ENERGY
PEB PEBBLEBROOK HOTEL TRUST
PBF PBF ENERGY INC. CLASS A
MTDR MATADOR RESOURCES COMPANY
MPC MARATHON PETROLEUM CORPORATION
LTRX LANTRONIX INC.
FRPT FRESHPET INC
EIX EDISON INTERNATIONAL
DRTTF DIRTT ENVIRONMENTAL SOLUTIONS
CMCO COLUMBUS MCKINNON CORPORATION
FLWS 1-800-FLOWERS.COM CL A
JELD JELD-WEN HOLDING INC.
FRAF FRANKLIN FINANCIAL SERVICES CO.
ELAN ELANCO ANIMAL HEALTH INC.
ABCL ABCELLERA BIOLOGICS
PFBX PEOPLES FINANCIAL CORP. (MISSISSIPPI)
JANX JANUX THERAPEUTICS INC
TNYA TENAYA THERAPEUTICS INC
IE IVANHOE ELECTRIC INC
ECAT BLACKROCK ESG CAP ALLOCATION TR
ELTX ANGION BIOMEDICA CORP
CVI CVR ENERGY
GAM INC.
GENERAL DE ALQUILER DE MAQUINARIA
03/08/25 March 8, 2025 1 EN
 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera Reports Full Year 2024 Business Results

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced financial results for the full year 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “In 2024 we made significant progress in transitioning from a platform company to a clinical-stage biotech, including advancing our internal pipeline and completing significant investments in our capabilities. We also maintained our strong cash position, closing the year with over $800 million in available liquidity to execute on our strategy,” said Carl Hansen...

February 27, 2025 1 EN
 PRESS RELEASE
Free
ABCL AbCellera Biolo...

AbCellera to Participate at Upcoming Investor Conferences in March

VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences: 45th Annual TD Cowen Health Care Conference, March 3-5 KeyBanc Capital Markets Healthcare Forum, March 18-19 Visit for additional information. About AbCellera Biologics Inc. (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and inter...

February 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch